Virus and radiation team up against rare sarcoma
NCT ID NCT06660810
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests a new approach for people with advanced soft tissue sarcoma that cannot be easily removed with surgery alone. Participants receive injections of a modified virus (TVEC) directly into the tumor along with standard radiation therapy before surgery. The goal is to see if this combination can destroy more of the tumor and improve outcomes. The study is in phase 2 and has enrolled 2 participants so far.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.